Report cover image

Biological Skin Substitutes Market Growth, Size, Trends Analysis- By Type, By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Publisher SPER Market Research Pvt. Ltd.
Published Dec 17, 2024
Length 245 Pages
SKU # SPER19472285

Description

Biological Skin Substitutes Market Growth, Size, Trends Analysis- By Type, By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033


Biological Skin Substitutes Market Introduction and Overview

According to SPER market research, ‘Global Biological Skin Substitutes Market Size- By Type, By Application, By End-Use – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ state that the Global Biological Skin Substitutes Market is predicted to reach 760.28 million by 2033 with a CAGR of 9.08%.

The use of biological skin replacements is essential in tissue engineering and wound care. Collagen or cultivated skin cells are examples of natural, biocompatible materials used to create these lab-grown substitutes. These alternatives help heal serious skin injuries including burns, ulcers, and surgical wounds because they are made to closely resemble the composition and functionality of normal human skin. In addition to provide instant relief by covering the exposed wound, biological skin substitutes encourage the skin’s natural healing process.

The market for biological skin substitutes was negatively impacted by the COVID-19 pandemic, mainly because of supply chain interruptions, decreased demand for non-urgent medical treatments, resource reallocation, financial strain on the healthcare system, and market uncertainty. All of these issues combined to cause a decline in the use of biological skin substitutes and a postponement of burn and chronic wound treatments. Thus, the market for biological skin substitutes was severely hampered in its growth and operational dynamics by the pandemic.

Scope of the report:

Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Type, By Application, By End-Use

Regions covered

North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered
Organogenesis, Inc, 3M, Integra LifeSciences, Smith and Nephew, Tissue Regenix, Mimedx, BSN medical, Stryker, Vericel Corporation, Mallinckrodt (Stratatech Corporation).

Biological Skin Substitutes Market Segmentation:

By Type: Based on the Type, Global Biological Skin Substitutes Market is segmented as; Human Donor Tissue-Derived Products, Acellular Animal-derived Products.

By Application: Based on the Application, Global Biological Skin Substitutes Market is segmented as; Acute Wounds, Chronic Wounds.

By End-Use: Based on the End-Use, Global Biological Skin Substitutes Market is segmented as; Hospitals, Outpatient Facilities, Research and Manufacturing.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

245 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Biological Skin Substitutes Market.
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Biological Skin Substitutes Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Biological Skin Substitutes Market
7. Global Biological Skin Substitutes Market, By Type (USD Million) 2020-2033
7.1. Global Biological Skin Substitutes Market Size, Share and Forecast, By Type, 2020-2026
7.2. Global Biological Skin Substitutes Market Size, Share and Forecast, By Type, 2027-2033
7.3. Human Donor Tissue-Derived Products
7.4. Acellular Animal-derived Products
8. Global Biological Skin Substitutes Market, By Application (USD Million) 2020-2033
8.1. Global Biological Skin Substitutes Market Size, Share and Forecast, By Application, 2020-2026
8.2. Global Biological Skin Substitutes Market Size, Share and Forecast, By Application, 2027-2033
8.3. Acute Wounds
8.4. Chronic Wounds
9. Global Biological Skin Substitutes Market, By End-Use (USD Million) 2020-2033
9.1. Global Biological Skin Substitutes Market Size, Share and Forecast, By End-Use, 2020-2026
9.2. Global Biological Skin Substitutes Market Size, Share and Forecast, By End-Use, 2027-2033
9.3. Hospitals
9.4. Outpatient Facilities
9.5. Research and Manufacturing
10. Global Biological Skin Substitutes Market Forecast, 2020-2033 (USD Million)
10.1. Global Biological Skin Substitutes Market Size and Market Share
11. Global Biological Skin Substitutes Market, By Region, 2020-2033 (USD Million)
11.1. Global Biological Skin Substitutes Market Size and Market Share By Region (2020-2026)
11.2. Global Biological Skin Substitutes Market Size and Market Share By Region (2027-2033)
11.3. Asia-Pacific
11.3.1. Australia
11.3.2. China
11.3.3. India
11.3.4. Japan
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific
11.4. Europe
11.4.1. France
11.4.2. Germany
11.4.3. Italy
11.4.4. Spain
11.4.5. United Kingdom
11.4.6. Rest of Europe
11.5. Middle East and Africa
11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates
11.5.3. Qatar
11.5.4. South Africa
11.5.5. Egypt
11.5.6. Morocco
11.5.7. Nigeria
11.5.8. Rest of Middle-East and Africa
11.6. North America
11.6.1. Canada
11.6.2. Mexico
11.6.3. United States
11.7. Latin America
11.7.1. Argentina
11.7.2. Brazil
11.7.3. Rest of Latin America
12. Company Profile
12.1. Organogenesis, Inc
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. 3M
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Integra LifeSciences
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Smith and Nephew
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Tissue Regenix
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Mimedx
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. BSN medical
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Stryker
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Vericel Corporation
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Mallinckrodt (Stratatech Corporation)
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us